| Elizabeth Marie Confalone, DPM | |
|
26908 Detroit Rd, #200, Westlake, OH 44145-2398 | |
| (440) 250-8660 | |
| (440) 250-8639 |
| Full Name | Elizabeth Marie Confalone |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 29 Years |
| Location | 26908 Detroit Rd, Westlake, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891882296 | NPI | - | NPPES |
| 2037012 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 36003007 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital Home Care Services, Inc | Warrensville hts, OH | Home health agency |
| Uh St John Medical Center | Westlake, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| University Hospitals - Elyria Medical Center | Elyria, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
RXi Pharmaceuticals Corporation today announced that Stephen J. DiPalma, has resigned as Executive Vice President of Business Operations and Chief Financial Officer to pursue other opportunities, effective August 28, 2009.
Healthy people who contribute DNA samples for medical research see their relationship with researchers as sharing a trade secret, rather than participation in traditional medical research, according to a new study.
Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.
› Verified 3 days ago
| Provider Name | University Primary Care Practices Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
RXi Pharmaceuticals Corporation today announced that Stephen J. DiPalma, has resigned as Executive Vice President of Business Operations and Chief Financial Officer to pursue other opportunities, effective August 28, 2009.
Healthy people who contribute DNA samples for medical research see their relationship with researchers as sharing a trade secret, rather than participation in traditional medical research, according to a new study.
Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Marie Confalone, DPM 26908 Detroit Rd, #301, Westlake, OH 44145-2398 Ph: (440) 617-1823 | Elizabeth Marie Confalone, DPM 26908 Detroit Rd, #200, Westlake, OH 44145-2398 Ph: (440) 250-8660 |
News Archive
RXi Pharmaceuticals Corporation today announced that Stephen J. DiPalma, has resigned as Executive Vice President of Business Operations and Chief Financial Officer to pursue other opportunities, effective August 28, 2009.
Healthy people who contribute DNA samples for medical research see their relationship with researchers as sharing a trade secret, rather than participation in traditional medical research, according to a new study.
Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.
› Verified 3 days ago
Elizabeth M Confalone Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 29101 Health Campus Dr, Suite 200, Westlake, OH 44145 Phone: 440-892-6555 Fax: 440-835-1996 | |
Dr. David R Koris, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 29099 Health Campus Dr, Suite 345, Westlake, OH 44145 Phone: 440-835-6122 Fax: 440-899-4355 | |
Jason T Bakich Dpm Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 29101 Health Campus Dr, Westlake, OH 44145 Phone: 440-899-4399 | |
Anthony G Polito Dpm Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 29099 Health Campus Dr, Bldg 3 Ste 180, Westlake, OH 44145 Phone: 440-892-6628 | |
Coleman O. Clougherty, D.p.m., Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 29099 Health Campus Dr, Suite 180, Westlake, OH 44145 Phone: 440-892-6628 | |
Dr. Carol E Keshock, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 26908 Detroit Rd, Suite 200, Westlake, OH 44145 Phone: 440-892-6655 Fax: 440-871-9817 | |
Dr. John L Aron, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 27665 Southbridge Cir, Westlake, OH 44145 Phone: 216-409-3451 Fax: 440-235-8440 |